AdvisorShares Psychedelics ETF
PSIL
11 hedge funds and large institutions have $531K invested in AdvisorShares Psychedelics ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.41% less ownership
Funds ownership: 1.05% → 0.64% (-0.41%)
8% less funds holding
Funds holding: 12 → 11 (-1)
11% less capital invested
Capital invested by funds: $597K → $531K (-$66K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GG
Gofen & Glossberg
Chicago,
Illinois
|
+$15.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.36K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$956 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$59.7K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$46K |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$21.3K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$1K |
PSIL Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AdvisorShares Psychedelics ETF (PSIL) for Q3 2022, worth a combined $531K — down 11% from $597K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PSIL and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Gofen & Glossberg, adding an estimated $15.9K. The largest seller was Morgan Stanley, cutting an estimated $59.7K.
- 11 institutional investors held AdvisorShares Psychedelics ETF (PSIL) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $531K of AdvisorShares Psychedelics ETF stock for Q3 2022, down 11% quarter-over-quarter.
- 2 funds opened new AdvisorShares Psychedelics ETF positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest AdvisorShares Psychedelics ETF buyer in Q3 2022 was Gofen & Glossberg, an estimated $15.9K added.
- The largest AdvisorShares Psychedelics ETF seller in Q3 2022 was Morgan Stanley, an estimated $59.7K sold.
Based on aggregated 13F filings for Q3 2022.